Kevin J. Black add Akbarian-Tefaghi review and Hartmann opinion paper to DBS section  over 7 years ago

Commit id: 7a6ed8fd68a92f713ef03b8905b5596dc79bd605

deletions | additions      

       

### Neurosurgery  The center with the largest  DBS targets: cohort (Milan, Italy) provides a progress report \cite{26348012}. In 11 of 48 patients (23%), the device was removed after "inflammatory complications" or poor compliance with follow-up. In the remaining 37 patients, 29 had a more than 50% reduction in YGTSS scores (clinician-rated tic severity and impairment).  Porta and colleagues argue that  the patient's issues symptoms  beyond tics should be considered when a DBS  target is selected\cite{26739445} selected \cite{26739445}. Hartmann argues that our current state of knowledge better supports a narrower focus on tic reduction in choosing a DBS target .\cite{einstein}  |**Title** | **Comment** |  |:----------|:------------|  | \cite{26348012} | This is a progress report from the center with the largest DBS cohort (Milan, Italy). In 11 of 48 patients (23%), the device was removed after "inflammatory complications" or poor compliance with follow-up. In the remaining 37 patients, 29 had a more than 50% reduction in YGTSS scores (clinician-rated tic severity and impairment). |  | \cite{27199634} | "The International Deep Brain Stimulation Registry and Database for Gilles de la Tourette syndrome: How does it work?" |   | \cite{27098785}| DBS follow-up from China|  | \cite{26963088}| DBS follow-up study|  | \cite{26811866} | GPi DBS in TS |   | \cite{27548235} | A review on DBS in TS |  ### Other treatment